Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 15.20
+0.10 (0.66%)
At close: Aug 21, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 86.67 million as of August 21, 2026. Its market cap has decreased by -28.12% in one year.
Market Cap
86.67M
Enterprise Value
232.03M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
15.20
ChartMarket Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 86.67M, a decrease of -63.95%. That is a compound annual growth rate of -20.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 86.67M | -39.16% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.80B |
| Idorsia | 1.47B |
| Basilea Pharmaceutica AG | 813.64M |
| Newron Pharmaceuticals | 261.74M |
| Santhera Pharmaceuticals Holding AG | 251.92M |
| BioVersys AG | 147.80M |
| Molecular Partners AG | 130.91M |
| MindMaze Therapeutics Holding | 28.96M |